Search company, investor...

Predict your next investment

Non-Profit Foundation
braintumor.org

Investments

4

Portfolio Exits

1

Partners & Customers

1

About National Brain Tumor Society

National Brain Tumor Society (NBTS) is dedicated to help: empower individuals with information, online programs, caring support, and direct connections to others going through the same challenges; fund transformative research to lead more rapidly to new therapies for adult and pediatric brain tumors, and ultimately to cures; advocate for brain tumor patients, families, caregivers, healthcare professionals, and researchers.

Headquarters Location

124 Watertown Street Suite 2D

Watertown, Massachusetts, 02472,

United States

617-924-9997

Want to inform investors similar to National Brain Tumor Society about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest National Brain Tumor Society News

Levi Metheny Supports the National Brain Tumor Society

Nov 18, 2022

News Provided By Share This Article Levi Metheny has joined the 50/31 challenge to support the National Tumor Society by raising funds for brain tumor research. NEWTON, MA, UNITED STATES, November 17, 2022 / EINPresswire.com / -- Levi Metheny successfully completed the 50/31 challenge held by The National Brain Tumor Society (NBTS). The non-profit organization hosted a month-long fitness challenge to align with Brain Tumor Awareness Month in May. The challenge involves running 50 miles in 31 days in order to raise funds for brain tumor research. “I am humbled to participate in this challenge to raise awareness for a vital cause,” says Levi Metheny, a Sales Representative with the Dow Jones PIB Sales Team. “Through NBTS research, I believe we will continue to see progress in finding a cure for brain tumors.” Currently, there are an estimated 700,000 people in the United States living with primary brain tumor, and more than 88,000 cases are to be diagnosed in 2022, according to NBTS. The 50/31 challenge had over 170 runners and successfully raised $29,797 for NBTS as of March last year. The marathon encourages accountability, consistency, and pushing one’s mental and physical strength while contributing to an important issue. Levi Metheny attended the University at Albany where he earned his bachelor’s degree in Marketing and Management, was a three-year starter, and was named FCS Pre-Season All-American. He then went on to continue his education and received an MBA from Murray State University while completing his last season of football. Mr. Metheny also won the CAA All-Conference award and participated in volunteer initiatives through the school. When he was not on the field as a linebacker, he was supporting the team’s volunteer initiatives which included reading to elementary students and serving in local food pantries and soup kitchens. XXX To learn more about Levi Metheny, you can visit his Linkedin profile. Media Relations

National Brain Tumor Society Investments

4 Investments

National Brain Tumor Society has made 4 investments. Their latest investment was in Modifi Bio as part of their Seed VC on July 7, 2022.

CBI Logo

National Brain Tumor Society Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/28/2022

Seed VC

Modifi Bio

$6.4M

Yes

2

11/17/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

1/16/2019

Grant

Subscribe to see more

$99M

Subscribe to see more

10

8/5/2010

Grant - II

Subscribe to see more

Subscribe to see more

10

Date

7/28/2022

11/17/2021

1/16/2019

8/5/2010

Round

Seed VC

Series A

Grant

Grant - II

Company

Modifi Bio

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$6.4M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

10

National Brain Tumor Society Portfolio Exits

1 Portfolio Exit

National Brain Tumor Society has 1 portfolio exit. Their latest portfolio exit was Forte Biosciences on April 13, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/13/2017

IPO

$99M

Public

1

Date

4/13/2017

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

1

National Brain Tumor Society Partners & Customers

1 Partners and customers

National Brain Tumor Society has 1 strategic partners and customers. National Brain Tumor Society recently partnered with Yale Cancer Center on February 2, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

2/22/2022

Partner

United States

14:03 ET National Brain Tumor Society Launches DNA Damage Response Consortium with Yale

NEWTON , Mass. , Feb. 22 , 2022 / PRNewswire / -- Today , the National Brain Tumor Society announced the launch of its new flagship research initiative , the DNA Damage Response Consortium , in partnership with Yale Cancer Center .

3

Date

2/22/2022

Type

Partner

Business Partner

Country

United States

News Snippet

14:03 ET National Brain Tumor Society Launches DNA Damage Response Consortium with Yale

NEWTON , Mass. , Feb. 22 , 2022 / PRNewswire / -- Today , the National Brain Tumor Society announced the launch of its new flagship research initiative , the DNA Damage Response Consortium , in partnership with Yale Cancer Center .

Sources

3

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.